clinical trial · NCT04107051
Post-Marketing Surveillance Study of Nalmefene Hydrochloride Hydrate in Patients with Alcohol Dependence
Otsuka Pharmaceutical Co., Ltd.·—·completed·n = 533
Alcohol DependenceNalmefene Hydrochloride Hydrate
brief summary
The purpose of this study is to investigate the safety and the prognosis after achieving reduced alcohol intake in patients with alcohol dependence who received treatment for the reduction of alcohol intake in the routine clinical setting in Japan.
started
Oct 1, 2019
primary completion
Feb 7, 2023
completion
Feb 6, 2024
last updated
Mar 21, 2025
official title
Nalmefene Hydrochloride Hydrate Tablets 10mg Specified Drug-use Results Survey (the Safety and the Prognosis After Achieving Reduced Alcohol Intake)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol